Treatment outcomes in 1p19q co-deleted/partially deleted gliomas.
Authors
McNamara, Mairéad GJiang, H
Lim-Fat, M
Sahebjam, S
Kiehl, T
Karamchandani, J
Coire, C
Chung, C
Millar, B
Laperriere, N
Mason, W
Affiliation
Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, CanadaIssue Date
2017-05
Metadata
Show full item recordAbstract
Radiotherapy with procarbazine, lomustine, and vincristine improves overall survival (OS) in patients with 1p19q co-deleted anaplastic oligodendroglioma/anaplastic oligoastrocytoma.Citation
Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas. 2017, 44 (3):288-294 Can J Neurol SciJournal
The Canadian Journal of Neurological SciencesDOI
10.1017/cjn.2016.420PubMed ID
28488951Type
ArticleLanguage
enISSN
0317-1671ae974a485f413a2113503eed53cd6c53
10.1017/cjn.2016.420
Scopus Count
Collections
Related articles
- 1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas.
- Authors: Jiang H, Ren X, Cui X, Wang J, Jia W, Zhou Z, Lin S
- Issue date: 2013 Jun
- Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.
- Authors: Speirs CK, Simpson JR, Robinson CG, DeWees TA, Tran DD, Linette G, Chicoine MR, Dacey RG, Rich KM, Dowling JL, Leuthardt EC, Zipfel GJ, Kim AH, Huang J
- Issue date: 2015 Feb 1
- Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience.
- Authors: Frenel JS, Leux C, Loussouarn D, Le Loupp AG, Leclair F, Aumont M, Mervoyer A, Martin S, Denis MG, Campone M
- Issue date: 2013 Aug
- Treatment updates regarding anaplastic oligodendroglioma and anaplastic oligoastrocytoma.
- Authors: Khan KA, Abbasi AN, Ali N
- Issue date: 2014 Dec
- IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.
- Authors: Leeper HE, Caron AA, Decker PA, Jenkins RB, Lachance DH, Giannini C
- Issue date: 2015 Oct 6